NCT04652297View on ClinicalTrials.gov

Safety, Tolerability and Pharmacokinetics of Single and Multiple Oral Administration of HS-10356 in Healthy Volunteers

PHASE1UnknownINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

December 31, 2020

Primary Completion Date

August 31, 2021

Study Completion Date

August 31, 2021

Conditions
Healthy
Interventions
DRUG

HS-10356

Single dose of HS-10356

DRUG

Placebo

Single dose of Placebo

DRUG

HS-10356

Multiple doses of HS-10356

DRUG

Placebo

Multiple doses of Placebo

Trial Locations (1)

450000

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

Sponsors
All Listed Sponsors
lead

Jiangsu Hansoh Pharmaceutical Co., Ltd.

INDUSTRY